跳至主要内容
临床试验/ITMCTR2000003697
ITMCTR2000003697尚未招募4 期

Multi-center, Randomized, Double Blind and Placebo Controlled Clinical Trial on the Efficacy and Safety of Jinhua Qinggan Granules (JHQG) for the Treatment of COVID-19 Patients.

Center for Bioequivalence Studies and Clinical Research,Beijing Hospital of Traditional Chinese Medicine0 个研究点开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional study

入排标准

年龄范围
18 至 75(—)
性别
All

入选标准

  • 1. Aged 18-75 years male and female;
  • 2. Confirmed Coronavirus infection by real time RT-PCR;
  • 3. Mild cases of Coronavirus having main symptoms with minimum 2 grade (as mentioned in 7.1.2);
  • 4. The subject has signed the informed consent form.

排除标准

  • 1. Patients with moderate or critical Coronavirus infection confirmed by real time RT-PCR (rRT-PCR); cases meeting any of the following criteria:
  • (1) Lung lesions;
  • (2) Respiratory failure and requiring mechanical ventilation;
  • (3) Shock;
  • (4) With other organ failure that requires ICU cares;
  • 2. Severe primary health conditions associated with cardiovascular, cerebrovascular, pulmonary, hepatic, renal, endocrine and hematological diseases, hematopoietic system (above grade II of cardiac function; ALT & AST are 1.5 times higher than the normal value; Creatinine above the upper limit of normal value) and mental illness or serious diseases affecting their survival, such as cancer or AIDS;
  • 3. With severe cardiopulmonary dysfunction, cardiopulmonary insufficiency;
  • 4. Subjects, who took other antiviral, antibacterial, cough relieving, expectorant and antiasthmatic drugs within 3 days prior to the visit (including ß2 receptor agonists, anticholinergic agents, theophylline drugs, glucocorticoids, expectorant and Chinese Medicine.);
  • 5. Allergic individuals and those who are known to be allergic to experimental drugs;
  • 6. Pregnant women, lactating women or fertile women who are ready to conceive in 3 months;
  • 7. Subject, who has participated in the past 1 month in another clinical study;
  • 8. Subjects who are not suitable for the clinical trial based on investigators judgment.

研究者

发起方
Center for Bioequivalence Studies and Clinical Research,Beijing Hospital of Traditional Chinese Medicine

相似试验